Premium
RADIATION FREE THERAPY OR THE INITIAL TREATMENT OF GOOD PROGNOSIS EARLY NON‐BULKY HODGKIN LYMPHOMA, DEFINED BY A LOW METABOLIC TUMOR VOLUME AND A NEGATIVE PET‐2 ‐ RAFTING TRIAL
Author(s) -
Gallamini A.,
Walewski J.,
Rambaldi A.,
Viviani S.,
Sureda A.,
André M.,
Rossi C.,
Moccia A.,
Zucca E.,
Rossi D.,
Filippi A.,
Meignan M.,
Chauvie S.,
Zaucha J. M.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.158_2880
Subject(s) - medicine , oncology , radiation therapy , population , incidence (geometry) , clinical endpoint , nivolumab , lymphoma , hodgkin lymphoma , progression free survival , surrogate endpoint , abvd , randomized controlled trial , nuclear medicine , chemotherapy , cancer , immunotherapy , vincristine , cyclophosphamide , physics , environmental health , optics